Mendelspod Podcast

The 21st is the Century of Biology. A radical advancement in the knowledge of basic biology and human disease is transforming our world. We interview the heroes beneath the headlines.

News Tech News Natural Sciences Science & Medicine

Update frequency: every 5 days
Average duration: 27 minutes
Episodes: 503
Years Active: 2014 - 2025

Share to:

Returning to Old Biotech Model, OncoMed Boasts of Seven Drugs in Clinical Trials by Mid 2015

For many years, the trend in biotech was for drug development companies to pursue one or maybe two drug candidates, or assets, as they’re called in industry parlance. Go lean and attract the attenti…

00:25:19 | Tue 24 Feb 2015

Cutting through the Hype in Healthcare Innovation with David Shaywitz and Lisa Suennen

In today’s special studio interview, the health tech duo, David Shaywitz and Lisa Suennen, walk us through the changing paradigms around healthcare. They offer their thoughts on some of the new digi…

00:28:11 | Fri 20 Feb 2015

A Call to Consumers to Lead the Shift in Healthcare: Sharon Terry, Genetic Alliance

One of those attending the recent White House gathering where Obama announced the Precision Medicine Initiative was a woman who has worked tirelessly as a patient advocate for over twenty years. She…

00:16:24 | Tue 17 Feb 2015

In Autoimmune Disease, Finding Clarity Beyond the Genome: Stefan Muellner, Protagen

Today we bring you a story which fits nicely in the vein of personalized medicine. But this time with a twist.

We talk with the CEO of Protagen, a company that has developed a platform to find new b…

00:15:56 | Fri 13 Feb 2015

Myriad Settlements Mark End of an Era: Antoinette Konski on Gene Patents

This past month one of the most successful genetic testing companies, Myriad Genetics, has been settling one gene patent case after another. Also, the FDA has been attempting to regulate some very c…

00:28:24 | Tue 10 Feb 2015

David Schwartz on the Future of Sequencing

David Schwartz was focused on long read sequencing and the structural variations of the genome—the big picture—long before the current trend. His lab at the University of Wisconsin at Madison develo…

00:29:50 | Fri 06 Feb 2015

Not a Stenographer to Power: Luke Timmerman and the New 'Timmerman Report'

Just less than a year ago, the national biotech editor at Xconomy, Luke Timmerman, left his post. Yeah, he just left it. Gone was the regular Monday column that helped us all absorb the newest t…

00:18:00 | Tue 03 Feb 2015

FDA Will Take Time to Digest Comments on LDT Guidance, Says Liz Mansfield

We’re very pleased to have Liz Mansfield of the FDA on the program to finish up our current Special Report on LDTs Series. Liz is part of the team at the FDA working on the new guidance for the regul…

00:26:58 | Tue 27 Jan 2015

Future of Personalized Medicine at Stake, says Amy Miller of PMC about LDT Regulation

Amy Miller is the Executive Vice President for the Personalized Medicine Coalition (PMC) and joins us in our Special Report on LDTs Series. Though the PMC does not have a position on whether the FDA…

00:21:08 | Fri 23 Jan 2015

'A Good Year' with John LaMattina

Guest:

John LaMattina, Senior Partner, Pure Tech Ventures
Bio and Contact Info

Listen (6:27) Comparing drug approvals: 2014 with 1996

Listen (7:10) More rational drug development?

This is a public e…

00:28:54 | Mon 19 Jan 2015

An Exciting Time for Mass Spec: Paul Beresford, Biodesix

Guest:

Paul Beresford, VP of Bus Dev, Biodesix
Bio and Contact Info

Listen (4:47) VeriStrat - a test for non-small cell lung cancer

Listen (4:39) What do you anticipate on the regulatory front?

This…

00:20:11 | Thu 15 Jan 2015

Current Version of LDT Draft Guidance Means Much Fewer and Lower Quality Tests for Patients, Says Elaine Lyon of ARUP

Guest:

Elaine Lyon, Former President, AMP; Medical Director of Molecular Genetics, ARUP Laboratories
Bio and Contact Info

Listen (4:37) What is at stake here?

Listen (6:16) Is your message being he…

00:22:29 | Tue 13 Jan 2015

The Sad State of Biospecimen Science with David Rimm, Yale

Guest:

David Rimm, Professor of Pathology, Yale University School of Medicine
Bio and Contact Info

Listen (4:16) An unsexy science

Listen (5:36) A lack of certifications

This is a public episode. I…

00:28:28 | Thu 08 Jan 2015

Cancer 2014: The Year in Review with Anna Barker

Guest:

Anna Barker, Co-Director, Complex Adaptive Systems Center, ASU
Bio and Contact Info

Listen (3:21) Andy's challenge

Listen (4:39) The year of immunotherapy

This is a public episode. If you'd like…

00:33:10 | Tue 30 Dec 2014

Faces of Leadership in Diagnostics: Surbhi Sarna

Guest:

Surbhi Sarna, Founder, CEO, nVision Medical

Bio and Contact Info

Listen (4:43) Filling a void in female health innovation

Listen (4:31) Addressing the leading cause of infertility

This is a publ…

00:23:46 | Thu 18 Dec 2014

Historic Consensus Reached on Biospecimen Standards: Carolyn Compton, NBDA

Guest:

Carolyn Compton, Professor of Pathology, ASU
Bio and Contact Info

Listen (4:54) A historic new consensus

Listen (6:33) CAP committed to enforcement

This is a public episode. If you'd like to…

00:33:53 | Tue 16 Dec 2014

Setting Better Expectations for Genomic Medicine: Geoff Ginsburg, Duke University

Guest:

Geoffrey Ginsburg, Director, Duke Center for Applied Genomics and Precision Medicine
Bio and Contact Info

Listen (6:58) Genomic medicine occuring across the lifespan

This is a public episode.…

00:31:01 | Tue 09 Dec 2014

Test Driving Genomic Medicine: Thomas Quertermous, Stanford

Guest:

Thomas Quertermous, Director of Research, Division of Cardiovascular Medicine, Stanford University
Bio and Contact Info

Listen (7:45) Close, but not quite there

This is a public episode. If y…

00:33:28 | Wed 03 Dec 2014

The Silicon Valley Fantasy Trip: Sci-fi Author Kim Stanley Robinson Talks Life Science

Guest:

Kim Stanley Robinson, Sci-Fi Author
Bio and Contact Info

Listen (3:30) Creating plot when science wants to be boring

Listen (3:22) Genetics and the distant past

This is a public episode. If …

00:38:23 | Tue 25 Nov 2014

Faces of Leadership in Diagnostics: Mara Aspinall

Guest:

Mara Aspinall, Founder, DxInsights

Bio and Contact Info

Listen (2:43) DxInsights and EPEMED

Listen (3:53) Diagnostics 5.0

This is a public episode. If you'd like to discuss this with other subsc…

00:25:17 | Thu 20 Nov 2014

Disclaimer: The podcast and artwork embedded on this page are the property of Theral Timpson. This content is not affiliated with or endorsed by eachpod.com.

EachPod